Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-06-01 | Mr. Daniel R. HopgoodExec. VP & CFO | -148,00 | 41,63k | Sale to Issuer | 281,31 | 1,01k | -12,76% |
| 2025-12-29 | Mr. James E. DeVriesInsider | -1,25k | 0,00 | Other Disposition | - | 50,72k | -2,40% |
| 2026-04-16 | Mr. James E. DeVriesInsider | -198,00 | 54,51k | Sale to Issuer | 275,28 | 50,72k | -0,39% |
| 2026-04-17 | Mr. Srinivas SubramanianInsider | -1,20k | 336,00k | Automatic Disposition | 280,00 | 4,02k | -23,01% |
| 2026-04-17 | Mr. Srinivas SubramanianInsider | -1,90k | 327,47k | Derivative Exercise and Sale | 107,65 - 280,00 | 4,02k | - |
| 2026-04-15 | Dr. Milton M. MorrisIndependent Director | -245,00 | 67,10k | Verkauf | 273,87 | 1,83k | -11,78% |
| 2026-04-08 | Mr. Justin HallExec. VP of Medical & Fluid Solutions | -716,00 | 197,49k | Verkauf | 275,82 | 322,00 | -68,98% |
| 2026-02-27 | Ms. Sarah SiddiquiExec. VP & Chief HR Officer | -30,00 | 8,80k | Sale to Issuer | 293,44 | 2,26k | -1,31% |
| 2026-02-24 | Mr. Sundaram NagarajanPresident, CEO & Director | -41,80k | 5,35M | Derivative Exercise and Sale | 165,21 - 293,26 | 72,82k | - |
| 2026-02-23 | Mr. Joseph P. KelleyExec. VP of Industrial Precision Solutions Leader | -29,47k | 2,87M | Derivative Exercise and Sale | 189,72 - 293,07 | 291,00 | - |
| 2026-02-23 | Mr. Joseph P. KelleyExec. VP of Industrial Precision Solutions Leader | -2,31k | 669,42k | Verkauf | 289,00 - 295,26 | 291,00 | -88,81% |
| 2026-01-05 | Mr. Srinivas SubramanianInsider | -149,00 | 36,64k | Sale to Issuer | 245,89 | 5,21k | -2,78% |
| 2026-01-05 | Ms. Sarah SiddiquiExec. VP & Chief HR Officer | -117,00 | 28,77k | Sale to Issuer | 245,89 | 2,29k | -4,85% |
| 2026-01-05 | Mr. Sundaram NagarajanPresident, CEO & Director | -451,00 | 110,90k | Sale to Issuer | 245,89 | 72,70k | -0,62% |
| 2026-01-05 | Mr. James E. DeVriesInsider | -272,00 | 66,88k | Sale to Issuer | 245,89 | 53,68k | -0,50% |
| 2026-01-05 | Mr. Justin HallExec. VP of Medical & Fluid Solutions | -63,00 | 15,49k | Sale to Issuer | 245,89 | 1,04k | -5,74% |
| 2026-01-05 | Ms. Jennifer L. McDonoughExec. VP, General Counsel & Corporate Secretary | -391,00 | 96,14k | Sale to Issuer | 245,89 | 3,46k | -10,14% |
| 2026-01-05 | Mr. Joseph P. KelleyExec. VP of Industrial Precision Solutions Leader | -561,00 | 137,94k | Sale to Issuer | 245,89 | 2,31k | -19,53% |
| 2025-12-19 | Mr. Daniel R. HopgoodExec. VP & CFO | -118,00 | 28,36k | Sale to Issuer | 240,38 | 645,00 | -15,47% |
| 2025-12-19 | Ms. Jennifer L. McDonoughExec. VP, General Counsel & Corporate Secretary | -107,00 | 25,72k | Sale to Issuer | 240,38 | 2,93k | -3,52% |
| 2025-12-19 | Mr. Justin HallExec. VP of Medical & Fluid Solutions | -18,00 | 4,33k | Sale to Issuer | 240,38 | 925,00 | -1,91% |
| 2025-12-19 | Mr. Srinivas SubramanianInsider | -59,00 | 14,18k | Sale to Issuer | 240,38 | 4,84k | -1,20% |
| 2025-12-19 | Mr. Sundaram NagarajanPresident, CEO & Director | -734,00 | 176,44k | Sale to Issuer | 240,38 | 67,39k | -1,08% |
| 2025-12-19 | Ms. Sarah SiddiquiExec. VP & Chief HR Officer | -95,00 | 22,84k | Sale to Issuer | 240,38 | 2,00k | -4,53% |
| 2025-12-19 | Mr. Joseph P. KelleyExec. VP of Industrial Precision Solutions Leader | -208,00 | 50,00k | Sale to Issuer | 240,38 | 912,00 | -18,57% |
| 2025-12-19 | Mr. James E. DeVriesInsider | -308,00 | 74,04k | Sale to Issuer | 240,38 | 53,03k | -0,58% |
| 2025-12-01 | Mr. James E. DeVriesInsider | -213,00 | 50,06k | Sale to Issuer | 235,03 | 53,34k | -0,40% |
| 2025-12-01 | Ms. Jennifer L. McDonoughExec. VP, General Counsel & Corporate Secretary | -208,00 | 48,89k | Sale to Issuer | 235,03 | 2,80k | -6,92% |
| 2025-12-01 | Mr. Sundaram NagarajanPresident, CEO & Director | -1,42k | 334,45k | Sale to Issuer | 235,03 | 59,68k | -2,33% |
| 2025-12-01 | Ms. Sarah SiddiquiExec. VP & Chief HR Officer | -106,00 | 24,91k | Sale to Issuer | 235,03 | 1,89k | -5,32% |
| 2025-12-01 | Mr. Joseph P. KelleyExec. VP of Industrial Precision Solutions Leader | -448,00 | 105,29k | Sale to Issuer | 235,03 | 653,00 | -40,69% |
| 2025-12-01 | Mr. Srinivas SubramanianInsider | -106,00 | 24,91k | Sale to Issuer | 235,03 | 4,70k | -2,21% |
| 2025-12-01 | Mr. Justin HallExec. VP of Medical & Fluid Solutions | -36,00 | 8,46k | Sale to Issuer | 235,03 | 943,00 | -3,68% |
| 2025-11-10 | Mr. James E. DeVriesInsider | -9,10k | 1,48M | Derivative Exercise and Sale | 70,91 - 233,60 | 53,55k | - |
| 2025-11-03 | Dr. Milton M. MorrisIndependent Director | -265,00 | 61,22k | Automatic Disposition | 231,00 | 2,08k | -11,31% |
| 2025-10-31 | Mr. James E. DeVriesInsider | -268,00 | 62,16k | Sale to Issuer | 231,95 | 53,55k | -0,50% |
| 2025-10-21 | Mr. Joseph P. KelleyExec. VP of Industrial Precision Solutions Leader | -2,20k | 528,00k | Automatic Disposition | 240,00 | 92,00 | -95,99% |
| 2025-10-16 | Mr. Joseph P. KelleyExec. VP of Industrial Precision Solutions Leader | -2,30k | 534,50k | Automatic Disposition | 232,39 | 2,29k | -50,09% |
| 2025-08-01 | Mr. Srinivas SubramanianInsider | -10,00 | 2,09k | Sale to Issuer | 209,25 | 4,41k | -0,23% |
| 2025-07-10 | Mr. Stephen F. ShamrockInsider | -1,18k | 262,89k | Other Disposition | 223,17 | 391,00 | -75,08% |
| 2025-07-10 | Mr. Stephen F. ShamrockInsider | -976,00 | 0,00 | Other Derivative Disposition | 209,73 - 238,80 | 0,00 | -100,00% |
| 2025-06-13 | Mr. Stephen P. LovassInsider | -79,00 | 16,75k | Sale to Issuer | 211,99 | 4,87k | -1,60% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
